Mobocertinib is an EGFR inhibitor, designed for NSCLC patients with a specific type of EGFR mutation. It works by going after the EGFR to stop tumor growth. The pills are 40 mg each.
You take one a day, and you can take it with or without food—your pick. They come in bottles with 90 capsules.
Reviews
There are no reviews yet.